Jeroen G.
- Country
- The Netherlands
- Department
- Radiotherapy
Research Overview
- Evaluation of Bintrafusp Alfa Combined with Chemoradiation in Esophageal Squamous Cell Carcinoma: A Feasibility Study
- Phase II Multicenter Randomized Trial of Neoadjuvant Chemotherapy and Chemoradiotherapy Regimens in Resectable Gastric Adenocarcinoma: Docetaxel, Capecitabine, Paclitaxel, Oxaliplatin, Carboplatin
- Evaluation of Organ Preservation in Early-Stage Rectal Cancer Using Oxaliplatin, Capecitabine, and Radiotherapy with Additional Local or Systemic Treatment
Data & Insights
Has run more than one trial at 23 of 47 partner sites.
Specializations
Oncological Focus
This investigator specializes in the treatment of locally advanced rectal cancer, with particular emphasis on developing innovative therapeutic approaches for complex cases.
- Advanced Colorectal Oncology
- Gastrointestinal Cancer Treatment
- Rectal Cancer Management
The investigator explores therapeutic strategies focusing on pathological and clinical response rates in cancer treatment.
Treatment Innovation
The investigator's work centers on evaluating enhanced treatment protocols incorporating induction chemotherapy for improved patient outcomes.
- Combined Modality Treatment
- Advanced Chemotherapy Protocols
- Treatment Response Assessment
Their research explores the integration of chemotherapeutic approaches with established treatment modalities.
Clinical Evaluation
The investigator specializes in assessing treatment efficacy through comprehensive response evaluation methods.
- Response Rate Assessment
- Long-term Outcome Evaluation
- Clinical Response Monitoring
Their expertise includes measuring both immediate and sustained therapeutic responses in cancer treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.